Publicaciones recientes

Lista de publicaciones más recientes lideradas por la Unidad de Memoria del Hospital de Sant Pau:

  1. Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Arranz, J, Zhu, N, Rubio-Guerra, S et al. Res Sq 2023
    PMID:38168408

  2. Down Syndrome in a New Era for Alzheimer Disease. Rafii, MS, Fortea, J JAMA 2023
    PMID:37991807

  3. Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum. Illán-Gala, I, Lorca-Puls, DL, Tee, BL et al. Brain 2023
    PMID:37988272

  4. Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices. Grasso, SM, Wagner Rodríguez, CA, Montagut Colomer, N et al. J Alzheimers Dis 2023
    PMID:37980666

  5. Compounded inequality: racial disparity and Down syndrome. McGlinchey, E, Iulita, MF, Fortea, J et al. Lancet Public Health 2023
    PMID:37898515

  6. Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Zhu, N, Santos-Santos, M, Illán-Gala, I et al. Transl Neurodegener 2023
    PMID:37158972

  7. Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome. Iulita, MF, Bejanin, A, Vilaplana, E et al. Brain Commun 2023
    PMID:37056479

  8. Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome. Videla, L, Benejam, B, Carmona-Iragui, M et al. Alzheimers Dement 2023
    PMID:37038748

  9. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome. Rozalem Aranha, M, Iulita, MF, Montal, V et al. Alzheimers Dement 2023
    PMID:37021589

  10. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. Montoliu-Gaya, L, Alcolea, D, Ashton, NJ et al. EBioMedicine 2023
    PMID:37002988

  11. Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist. Alcolea, D, Beeri, MS, Rojas, JC et al. Neurology 2023
    PMID:36878698

  12. Correction: Cortical microstructure in primary progressive aphasia: a multicenter study. Illán-Gala, I, Montal, V, Borrego-Écija, S et al. Alzheimers Res Ther 2023
    PMID:36739431

  13. Amyloid precursor protein 𝛽CTF accumulates in synapses in sporadic and genetic forms of Alzheimer's disease. Ferrer-Raventós, P, Puertollano-Martín, D, Querol-Vilaseca, M et al. Neuropathol Appl Neurobiol 2023
    PMID:36702749

  14. Early Motor Changes in Genetic Frontotemporal Dementia. Lleó, A, Illán-Gala, I Neurology 2022
    PMID:36219793

  15. Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease. Benejam, B, Aranha, MR, Videla, L et al. Alzheimers Res Ther 2022
    PMID:36057615

  16. Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma. Valle-Tamayo, N, Pérez-González, R, Chiva-Blanch, G et al. J Vis Exp 2022
    PMID:35993755

  17. Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome. Videla, L, Benejam, B, Pegueroles, J et al. JAMA Netw Open 2022
    PMID:35930282

  18. Myelin loss in C9orf72 hexanucleotide expansion carriers. Sirisi, S, Querol-Vilaseca, M, Dols-Icardo, O et al. J Neurosci Res 2022
    PMID:35766328

  19. Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. Iulita, MF, Garzón Chavez, D, Klitgaard Christensen, M et al. JAMA Netw Open 2022
    PMID:35604690

  20. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration. Illán-Gala, I, Nigro, S, VandeVrede, L et al. JAMA Netw Open 2022
    PMID:35486397

  21. Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease. Aranha, MR, Fortea, J, Carmona-Iragui, M et al. Neurology 2022
    PMID:35470138

  22. Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications. Altuna, M, Olmedo-Saura, G, Carmona-Iragui, M et al. Int J Mol Sci 2022
    PMID:35457126

  23. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Cervantes González, A, Irwin, DJ, Alcolea, D et al. Mol Neurodegener 2022
    PMID:35395770

  24. Fluid markers of synapse degeneration in synucleinopathies. Cervantes González, A, Belbin, O J Neural Transm (Vienna) 2022
    PMID:35147800

  25. Cortical microstructure in primary progressive aphasia: a multicenter study. Illán-Gala, I, Montal, V, Borrego-Écija, S et al. Alzheimers Res Ther 2022
    PMID:35139897

  26. Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Reyes-Leiva, D, Dols-Icardo, O, Sirisi, S et al. Front Neurol 2021
    PMID:35115992

  27. The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone. Delaby, C, Estellés, T, Zhu, N et al. Alzheimers Res Ther 2022
    PMID:35105351

  28. [Preliminary study of the temporal variables of continuous speech in patients with neurodegenerative syndromes of the frontotemporal lobar degeneration spectrum]. Baqué, L, Machuca, MJ, Santos-Santos, MA et al. Rev Neurol 2022
    PMID:35014018

  29. Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Zhu, N, Santos-Santos, M, Illán-Gala, I et al. Transl Neurodegener 2021
    PMID:34893073

  30. Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat. Querol-Vilaseca, M, Sirisi, S, Molina-Porcel, L et al. Neuropathol Appl Neurobiol 2022
    PMID:34825396

Search PubMed